{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:28:20Z","timestamp":1793831300905,"version":"4.6.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WE4461\/2-1+2"],"award-info":[{"award-number":["WE4461\/2-1+2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FL-276\/8-1 and 2"],"award-info":[{"award-number":["FL-276\/8-1 and 2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 213\/973-1"],"award-info":[{"award-number":["INST 213\/973-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovationsforum","award":["IF-017-22"],"award-info":[{"award-number":["IF-017-22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pulmonary arterial hypertension (PAH) is a life-threatening disease with limited survival. Herein, we propose the pharmacological inhibition of Gq proteins as a novel concept to counteract pulmonary vasoconstriction and proliferation\/migration of pulmonary artery smooth muscle cells (PASMCs) in PAH. We demonstrate that the specific pan-Gq inhibitor FR900359 (FR) induced a strong vasorelaxation in large and small pulmonary arteries in mouse, pig, and human subjects ex vivo. Vasorelaxation by FR proved at least as potent as the currently used triple therapy. We also provide in vivo evidence that local pulmonary application of FR prevented right ventricular systolic pressure increase in healthy mice as well as in mice suffering from hypoxia (Hx)-induced pulmonary hypertension (PH). In addition, we demonstrate that chronic application of FR prevented and also reversed Sugen (Su)Hx-induced PH in mice. We also demonstrate that Gq inhibition reduces proliferation and migration of PASMCs in vitro. Thus, our work illustrates a dominant role of Gq proteins for pulmonary vasoconstriction as well as remodeling and proposes direct Gq inhibition as a powerful pharmacological strategy in PH.<\/jats:p>","DOI":"10.1038\/s44321-024-00096-0","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T06:11:29Z","timestamp":1720419089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5086-0605","authenticated-orcid":false,"given":"Alexander","family":"Seidinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8519-0661","authenticated-orcid":false,"given":"Marion","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Pfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Matthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6172-4478","authenticated-orcid":false,"given":"Sarah","family":"Rieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3733-3443","authenticated-orcid":false,"given":"Judith","family":"Alenfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele M","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8805-6831","authenticated-orcid":false,"given":"Alexander","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi","family":"Kostenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Klinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9202-8363","authenticated-orcid":false,"given":"Bernd K","family":"Fleischmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-6363","authenticated-orcid":false,"given":"Daniela","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"96_CR1","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/S0735-1097(98)00091-6","volume":"31","author":"S Abdel Kafi","year":"1998","unstructured":"Abdel Kafi S, M\u00e9lot C, Vachi\u00e9ry J-L, Brimioulle S, Naeije R (1998) Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. J Am Coll Cardiol 31:1372\u20131376","journal-title":"J Am Coll Cardiol"},{"key":"96_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/sj.bjp.0707338","volume":"151","author":"VR Alapati","year":"2007","unstructured":"Alapati VR, McKenzie C, Blair A, Kenny D, MacDonald A, Shaw AM (2007) Mechanisms of U46619- and 5-HT-induced contraction of bovine pulmonary arteries: role of chloride ions. Br J Pharm 151:1224\u20131234","journal-title":"Br J Pharm"},{"key":"96_CR3","doi-asserted-by":"publisher","first-page":"eaau5948","DOI":"10.1126\/scisignal.aau5948","volume":"12","author":"S Annala","year":"2019","unstructured":"Annala S, Feng X, Shridhar N, Eryilmaz F, Patt J, Yang J, Pfeil EM, Cervantes-Villagrana RD, Inoue A, H\u00e4berlein F et al (2019) Direct targeting of G\u03b1q and G\u03b111 oncoproteins in cancer cells. Sci Signal 12:eaau5948","journal-title":"Sci Signal"},{"key":"96_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1165\/rcmb.2015-0290MA","volume":"54","author":"Y Bai","year":"2016","unstructured":"Bai Y, Krishnamoorthy N, Patel KR, Rosas I, Sanderson MJ, Ai X (2016) Cryopreserved human precision-cut lung slices as a bioassay for live tissue banking. A viability study of bronchodilation with bitter-taste receptor agonists. Am J Respir Cell Mol Biol 54:656\u2013663","journal-title":"Am J Respir Cell Mol Biol"},{"key":"96_CR5","doi-asserted-by":"publisher","first-page":"L472","DOI":"10.1152\/ajplung.00101.2006","volume":"293","author":"SA Barman","year":"2007","unstructured":"Barman SA (2007) Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C. Am J Physiol Lung Cell Mol Physiol 293:L472\u20139","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"96_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.prostaglandins.2015.09.002","volume":"121","author":"C Benyahia","year":"2015","unstructured":"Benyahia C, Ozen G, Orie N, Ledwozyw A, Louedec L, Li F, Senbel AM, Silverstein A, Danel C, Longrois D et al (2015) Ex vivo relaxations of pulmonary arteries induced by prostacyclin mimetics are highly dependent of the precontractie agents. Prostaglandins Other Lipid Mediat 121:46\u201352","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"96_CR7","doi-asserted-by":"publisher","first-page":"e136939","DOI":"10.1172\/JCI136939","volume":"131","author":"EM Berghausen","year":"2021","unstructured":"Berghausen EM, Janssen W, Vantler M, Gnatzy-Feik LL, Krause M, Behringer A, Joseph C, Zierden M, Freyhaus HT, Klinke A et al (2021) Disrupted PI3K subunit p110\u03b1 signaling protects against pulmonary hypertension and reverses established disease in rodents. J Clin Investig 131:e136939","journal-title":"J Clin Investig"},{"key":"96_CR8","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.121.319971","volume":"130","author":"O Boucherat","year":"2022","unstructured":"Boucherat O, Agrawal V, Lawrie A, Bonnet S (2022) The latest in animal models of pulmonary hypertension and right ventricular failure. Circ Res 130:1466\u20131486","journal-title":"Circ Res"},{"key":"96_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1378\/chest.120.3.809","volume":"120","author":"E Bressollette","year":"2001","unstructured":"Bressollette E, Dupuis J, Bonan R, Doucet S, Cernacek P, Tardif JC (2001) Intravascular ultrasound assessment of pulmonary vascular disease in patients with pulmonary hypertension. Chest 120:809\u2013815","journal-title":"Chest"},{"key":"96_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1378\/chest.10-1166","volume":"140","author":"LM Brown","year":"2011","unstructured":"Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K et al (2011) Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest 140:19\u201326","journal-title":"Chest"},{"key":"96_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.phrs.2016.01.003","volume":"105","author":"ND Camp","year":"2016","unstructured":"Camp ND, Lee K-S, Cherry A, Wacker-Mhyre JL, Kountz TS, Park J-M, Harris D-A, Estrada M, Stewart A, Stella N et al (2016) Dynamic mass redistribution reveals diverging importance of PDZ-ligands for G protein-coupled receptor pharmacodynamics. Pharm Res 105:13\u201321","journal-title":"Pharm Res"},{"key":"96_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024969","volume":"11","author":"KY Chang","year":"2022","unstructured":"Chang KY, Duval S, Badesch DB, Bull TM, Chakinala MM, de Marco T, Frantz RP, Hemnes A, Mathai SC, Rosenzweig EB et al (2022) Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry. J Am Heart Assoc 11:e024969","journal-title":"J Am Heart Assoc"},{"key":"96_CR13","first-page":"62","volume":"2014","author":"AH Chester","year":"2014","unstructured":"Chester AH, Yacoub MH (2014) The role of endothelin-1 in pulmonary arterial hypertension. Glob Cardiol Sci Pr 2014:62\u201378","journal-title":"Glob Cardiol Sci Pr"},{"key":"96_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/NEJM199207093270202","volume":"327","author":"BW Christman","year":"1992","unstructured":"Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE (1992) An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327:70\u201375","journal-title":"N Engl J Med"},{"key":"96_CR15","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/anie.201707996","volume":"57","author":"M Cr\u00fcsemann","year":"2018","unstructured":"Cr\u00fcsemann M, Reher R, Schamari I, Brachmann AO, Ohbayashi T, Kuschak M, Malfacini D, Seidinger A, Pinto-Carb\u00f3 M, Richarz R et al (2018) Heterologous expression, biosynthetic studies, and ecological function of the selective Gq-signaling inhibitor FR900359. Angew Chem Int Ed Engl 57:836\u2013840","journal-title":"Angew Chem Int Ed Engl"},{"key":"96_CR16","unstructured":"de Mey JGR, Compeer MG, Meens MJPMT (2009) Endothelin-1, an endogenous irreversible agonist in search of an allosteric inhibitor. Mol Cell Pharmacol 1(5):246\u2013257"},{"key":"96_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.105.581405","volume":"113","author":"R Dumitrascu","year":"2006","unstructured":"Dumitrascu R, Weissmann N, Ghofrani HA, Dony E, Beuerlein K, Schmidt H, Stasch J-P, Gnoth MJ, Seeger W, Grimminger F et al (2006) Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 113:286\u2013295","journal-title":"Circulation"},{"key":"96_CR18","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1161\/CIRCULATIONAHA.105.591321","volume":"113","author":"S Eddahibi","year":"2006","unstructured":"Eddahibi S, Guignabert C, Barlier-Mur A-M, Dewachter L, Fadel E, Dartevelle P, Humbert M, Simonneau G, Hanoun N, Saurini F et al (2006) Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation 113:1857\u20131864","journal-title":"Circulation"},{"key":"96_CR19","doi-asserted-by":"publisher","first-page":"2003957","DOI":"10.1183\/13993003.03957-2020","volume":"58","author":"CE Evans","year":"2021","unstructured":"Evans CE, Cober ND, Dai Z, Stewart DJ, Zhao Y-Y (2021) Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J 58:2003957","journal-title":"Eur Respir J"},{"key":"96_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/BF00501438","volume":"326","author":"M Frenken","year":"1984","unstructured":"Frenken M, Kaumann AJ (1984) Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf. Naunyn Schmiedebergs Arch Pharm 326:334\u2013339","journal-title":"Naunyn Schmiedebergs Arch Pharm"},{"key":"96_CR21","doi-asserted-by":"publisher","first-page":"29888","DOI":"10.1074\/jbc.M803880200","volume":"283","author":"J Gavard","year":"2008","unstructured":"Gavard J, Gutkind JS (2008) Protein kinase C-related kinase and ROCK are required for thrombin-induced endothelial cell permeability downstream from Galpha12\/13 and Galpha11\/q. J Biol Chem 283:29888\u201329896","journal-title":"J Biol Chem"},{"key":"96_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa1209657","volume":"369","author":"H-A Ghofrani","year":"2013","unstructured":"Ghofrani H-A, D\u2019Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, Mayer E, Simonneau G, Wilkins MR, Fritsch A et al (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N. Engl J Med 369:319\u2013329","journal-title":"N. Engl J Med"},{"key":"96_CR23","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","volume":"328","author":"A Giaid","year":"1993","unstructured":"Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl J Med 328:1732\u20131739","journal-title":"N. Engl J Med"},{"key":"96_CR24","doi-asserted-by":"publisher","first-page":"ra78","DOI":"10.1126\/scisignal.2000511","volume":"2","author":"B Haas","year":"2009","unstructured":"Haas B, Mayer P, Jennissen K, Scholz D, Berriel Diaz M, Bloch W, Herzig S, F\u00e4ssler R, Pfeifer A (2009) Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis. Sci Signal 2:ra78","journal-title":"Sci Signal"},{"key":"96_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12137","volume":"12","author":"PM Hendriks","year":"2022","unstructured":"Hendriks PM, Staal DP, van de Groep LD, van den Toorn LM, Chandoesing PP, Kauling RM, Mager H-J, van den Bosch AE, Post MC, Boomars KA (2022) The evolution of survival of pulmonary arterial hypertension over 15 years. Pulm Circ 12:e12137","journal-title":"Pulm Circ"},{"key":"96_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","volume":"99","author":"P Herv\u00e9","year":"1995","unstructured":"Herv\u00e9 P, Launay J-M, Scrobohaci M-L, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L (1995) Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99:249\u2013254","journal-title":"Am J Med"},{"key":"96_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00395-012-0257-5","volume":"107","author":"K Herz","year":"2012","unstructured":"Herz K, Heinemann JC, Hesse M, Ottersbach A, Geisen C, Fuegemann CJ, R\u00f6ll W, Fleischmann BK, Wenzel D (2012) Live monitoring of small vessels during development and disease using the flt-1 promoter element. Basic Res Cardiol 107:257","journal-title":"Basic Res Cardiol"},{"key":"96_CR28","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P et al (2022) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43:3618\u20133731","journal-title":"Eur Heart J"},{"key":"96_CR29","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.2147\/IJN.S63190","volume":"9","author":"PP Jain","year":"2014","unstructured":"Jain PP, Leber R, Nagaraj C, Leitinger G, Lehofer B, Olschewski H, Olschewski A, Prassl R, Marsh LM (2014) Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries. Int J Nanomed 9:3249\u20133261","journal-title":"Int J Nanomed"},{"key":"96_CR30","doi-asserted-by":"publisher","first-page":"ra62","DOI":"10.1126\/scisignal.2002867","volume":"5","author":"K Jennissen","year":"2012","unstructured":"Jennissen K, Siegel F, Liebig-Gonglach M, Hermann M-R, Kipschull S, van Dooren S, Kunz WS, F\u00e4ssler R, Pfeifer A (2012) A VASP-Rac-soluble guanylyl cyclase pathway controls cGMP production in adipocytes. Sci Signal 5:ra62","journal-title":"Sci Signal"},{"key":"96_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/2045894019895451","volume":"9","author":"A Jose","year":"2019","unstructured":"Jose A, Eckman MH, Elwing JM (2019) Anticoagulation in pulmonary arterial hypertension: a decision analysis. Pulm Circ 9:2045894019895451","journal-title":"Pulm Circ"},{"key":"96_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.yjmcc.2012.06.004","volume":"53","author":"Y-K Ju","year":"2012","unstructured":"Ju Y-K, Woodcock EA, Allen DG, Cannell MB (2012) Inositol 1,4,5-trisphosphate receptors and pacemaker rhythms. J Mol Cell Cardiol 53:375\u2013381","journal-title":"J Mol Cell Cardiol"},{"key":"96_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/2045893217719250","volume":"7","author":"M Kingman","year":"2017","unstructured":"Kingman M, Archer-Chicko C, Bartlett M, Beckmann J, Hohsfield R, Lombardi S (2017) Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension. Pulm Circ 7:598\u2013608","journal-title":"Pulm Circ"},{"key":"96_CR34","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ehf2.14611","volume":"11","author":"T Kramer","year":"2024","unstructured":"Kramer T, Nattmann P, Gerhardt F, Stafiej P, Dumitrescu D, Freyhaus HT, Wi\u00dfm\u00fcller M, Hohmann C, Baldus S, Rosenkranz S (2024) Impact of rapid sequential combination therapy on distinct haemodynamic measures in newly diagnosed pulmonary arterial hypertension. ESC Heart Fail 11:1540\u20131552","journal-title":"ESC Heart Fail"},{"key":"96_CR35","doi-asserted-by":"publisher","first-page":"10250","DOI":"10.1074\/jbc.M511551200","volume":"281","author":"AM Krumins","year":"2006","unstructured":"Krumins AM, Gilman AG (2006) Targeted knockdown of G protein subunits selectively prevents receptor-mediated modulation of effectors and reveals complex changes in non-targeted signaling proteins. J Biol Chem 281:10250\u201310262","journal-title":"J Biol Chem"},{"key":"96_CR36","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1111\/bph.14960","volume":"177","author":"M Kuschak","year":"2020","unstructured":"Kuschak M, Namasivayam V, Rafehi M, Voss JH, Garg J, Schlegel JG, Abdelrahman A, Kehraus S, Reher R, K\u00fcppers J et al (2020) Cell-permeable high-affinity tracers for Gq proteins provide structural insights, reveal distinct binding kinetics and identify small molecule inhibitors. Br J Pharm 177:1898\u20131916","journal-title":"Br J Pharm"},{"key":"96_CR37","first-page":"44","volume":"19","author":"JW Landsberg","year":"2004","unstructured":"Landsberg JW, Yuan JX-J (2004) Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation. N. Physiol Sci 19:44\u201350","journal-title":"N. Physiol Sci"},{"key":"96_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1165\/rcmb.2010-0428OC","volume":"46","author":"Y Li","year":"2012","unstructured":"Li Y, Connolly M, Nagaraj C, Tang B, B\u00e1lint Z, Popper H, Smolle-Juettner FM, Lindenmann J, Kwapiszewska G, Aaronson PI et al (2012) Peroxisome proliferator-activated receptor-\u03b2\/\u03b4, the acute signaling factor in prostacyclin-induced pulmonary vasodilation. Am J Respir Cell Mol Biol 46:372\u2013379","journal-title":"Am J Respir Cell Mol Biol"},{"key":"96_CR39","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/S0028-3908(00)00080-0","volume":"39","author":"MD Mark","year":"2000","unstructured":"Mark MD, Ruppersberg JP, Herlitze S (2000) Regulation of GIRK channel deactivation by G\u03b1q and G\u03b1i\/o pathways. Neuropharmacology 39:2360\u20132373","journal-title":"Neuropharmacology"},{"key":"96_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pharmthera.2016.10.008","volume":"170","author":"L Maroteaux","year":"2017","unstructured":"Maroteaux L, Ayme-Dietrich E, Aubertin-Kirch G, Banas S, Quentin E, Lawson R, Monassier L (2017) New therapeutic opportunities for 5-HT2 receptor ligands. Pharm Ther 170:14\u201336","journal-title":"Pharm Ther"},{"key":"96_CR41","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1161\/CIRCRESAHA.122.321041","volume":"131","author":"B Masson","year":"2022","unstructured":"Masson B, Le Ribeuz H, Sabourin J, Laubry L, Woodhouse E, Foster R, Ruchon Y, Dutheil M, Bo\u00ebt A, Ghigna M-R et al (2022) Orai1 inhibitors as potential treatments for pulmonary arterial hypertension. Circ Res 131:e102\u2013e119","journal-title":"Circ Res"},{"key":"96_CR42","doi-asserted-by":"publisher","first-page":"L246","DOI":"10.1152\/ajplung.00011.2023","volume":"325","author":"B Masson","year":"2023","unstructured":"Masson B, Saint-Martin Willer A, Dutheil M, Penalva L, Le Ribeuz H, El Jekmek K, Ruchon Y, Cohen-Kaminsky S, Sabourin J, Humbert M et al (2023) Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 325:L246\u2013L261","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"96_CR43","doi-asserted-by":"publisher","first-page":"eaag2288","DOI":"10.1126\/scitranslmed.aag2288","volume":"9","author":"M Matthey","year":"2017","unstructured":"Matthey M, Roberts R, Seidinger A, Simon A, Schr\u00f6der R, Kuschak M, Annala S, K\u00f6nig GM, M\u00fcller CE, Hall IP et al (2017) Targeted inhibition of Gq signaling induces airway relaxation in mouse models of asthma. Sci Transl Med 9:eaag2288","journal-title":"Sci Transl Med"},{"key":"96_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pharmthera.2015.01.009","volume":"150","author":"JD McCorvy","year":"2015","unstructured":"McCorvy JD, Roth BL (2015) Structure and function of serotonin G protein-coupled receptors. Pharm Ther 150:129\u2013142","journal-title":"Pharm Ther"},{"key":"96_CR45","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1476-5381.2008.00084.x","volume":"157","author":"C McKenzie","year":"2009","unstructured":"McKenzie C, MacDonald A, Shaw AM (2009) Mechanisms of U46619-induced contraction of rat pulmonary arteries in the presence and absence of the endothelium. Br J Pharm 157:581\u2013596","journal-title":"Br J Pharm"},{"key":"96_CR46","doi-asserted-by":"publisher","first-page":"e10917","DOI":"10.1371\/journal.pone.0010917","volume":"5","author":"MJPMT Meens","year":"2010","unstructured":"Meens MJPMT, Compeer MG, Hackeng TM, van Zandvoort MA, Janssen BJA, de Mey JGR (2010) Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1\/ET(A)-receptor complexes. PLoS ONE 5:e10917","journal-title":"PLoS ONE"},{"key":"96_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.phrs.2019.01.012","volume":"141","author":"MM Meleka","year":"2019","unstructured":"Meleka MM, Edwards AJ, Xia J, Dahlen SA, Mohanty I, Medcalf M, Aggarwal S, Moeller KD, Mortensen OV, Osei-Owusu P (2019) Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for Gq\/11 class G proteins. Pharm Res 141:264\u2013275","journal-title":"Pharm Res"},{"key":"96_CR48","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jacbts.2022.02.018","volume":"7","author":"M M\u00fcller","year":"2022","unstructured":"M\u00fcller M, Bischof C, Kapries T, Wollnitza S, Liechty C, Gei\u00dfen S, Schubert T, Opacic D, Ger\u00e7ek M, Fortmeier V et al (2022) Right heart failure in mice upon pressure overload is promoted by mitochondrial oxidative stress. JACC Basic Transl Sci 7:658\u2013677","journal-title":"JACC Basic Transl Sci"},{"key":"96_CR49","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1096\/fj.201700684RR","volume":"32","author":"V Neumann","year":"2018","unstructured":"Neumann V, Knies R, Seidinger A, Simon A, Lorenz K, Matthey M, Breuer J, Wenzel D (2018) The \u03b22 agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via \u03b1 adrenoceptor antagonism. FASEB J 32:2519\u20132530","journal-title":"FASEB J"},{"key":"96_CR50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/38284","volume":"389","author":"S Offermanns","year":"1997","unstructured":"Offermanns S, Toombs CF, Hu YH, Simon MI (1997) Defective platelet activation in G alpha(q)-deficient mice. Nature 389:183\u2013186","journal-title":"Nature"},{"key":"96_CR51","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.molcel.2020.10.027","volume":"80","author":"EM Pfeil","year":"2020","unstructured":"Pfeil EM, Brands J, Merten N, V\u00f6gtle T, Vescovo M, Rick U, Albrecht I-M, Heycke N, Kawakami K, Ono Y et al (2020) Heterotrimeric G protein subunit G\u03b1q is a master switch for G\u03b2\u03b3-mediated calcium mobilization by Gi-coupled GPCRs. Mol Cell 80:940\u2013954.e6","journal-title":"Mol Cell"},{"key":"96_CR52","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.rmed.2005.03.026","volume":"99","author":"IR Preston","year":"2005","unstructured":"Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS (2005) Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Respir Med 99:1501\u20131510","journal-title":"Respir Med"},{"key":"96_CR53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.healun.2015.10.002","volume":"35","author":"T Roldan","year":"2016","unstructured":"Roldan T, Landzberg MJ, Deicicchi DJ, Atay JK, Waxman AB (2016) Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge. J Heart Lung Transpl 35:151\u2013164","journal-title":"J Heart Lung Transpl"},{"key":"96_CR54","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa012212","volume":"346","author":"LJ Rubin","year":"2002","unstructured":"Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I et al (2002) Bosentan therapy for pulmonary arterial hypertension. N. Engl J Med 346:896\u2013903","journal-title":"N. Engl J Med"},{"key":"96_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"R Santos","year":"2017","unstructured":"Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al-Lazikani B, Hersey A, Oprea TI et al (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16:19\u201334","journal-title":"Nat Rev Drug Discov"},{"key":"96_CR56","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/nm.3695","volume":"20","author":"R Savai","year":"2014","unstructured":"Savai R, Al-Tamari HM, Sedding D, Kojonazarov B, Muecke C, Teske R, Capecchi MR, Weissmann N, Grimminger F, Seeger W et al (2014) Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension. Nat Med 20:1289\u20131300","journal-title":"Nat Med"},{"key":"96_CR57","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1172\/JCI24838","volume":"115","author":"RT Schermuly","year":"2005","unstructured":"Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W et al (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115:2811\u20132821","journal-title":"J Clin Invest"},{"key":"96_CR58","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1021\/acsptsci.1c00021","volume":"4","author":"JG Schlegel","year":"2021","unstructured":"Schlegel JG, Tahoun M, Seidinger A, Voss JH, Kuschak M, Kehraus S, Schneider M, Matthey M, Fleischmann BK, K\u00f6nig GM et al (2021) Macrocyclic Gq protein inhibitors FR900359 and\/or YM-254890\u2013fit for translation? ACS Pharmacol Transl Sci 4:888\u2013897","journal-title":"ACS Pharmacol Transl Sci"},{"key":"96_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10156","volume":"6","author":"R Schrage","year":"2015","unstructured":"Schrage R, Schmitz A-L, Gaffal E, Annala S, Kehraus S, Wenzel D, B\u00fcllesbach KM, Bald T, Inoue A, Shinjo Y et al (2015) The experimental power of FR900359 to study Gq-regulated biological processes. Nat Commun 6:10156","journal-title":"Nat Commun"},{"key":"96_CR60","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nbt.1671","volume":"28","author":"R Schr\u00f6der","year":"2010","unstructured":"Schr\u00f6der R, Janssen N, Schmidt J, Kebig A, Merten N, Hennen S, M\u00fcller A, Bl\u00e4ttermann S, Mohr-Andr\u00e4 M, Zahn S et al (2010) Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements. Nat Biotechnol 28:943\u2013949","journal-title":"Nat Biotechnol"},{"key":"96_CR61","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/nprot.2011.386","volume":"6","author":"R Schr\u00f6der","year":"2011","unstructured":"Schr\u00f6der R, Schmidt J, Bl\u00e4ttermann S, Peters L, Janssen N, Grundmann M, Seemann W, Kaufel D, Merten N, Drewke C et al (2011) Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells. Nat Protoc 6:1748\u20131760","journal-title":"Nat Protoc"},{"key":"96_CR62","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1183\/09031936.00013908","volume":"32","author":"N Sommer","year":"2008","unstructured":"Sommer N, Dietrich A, Schermuly RT, Ghofrani HA, Gudermann T, Schulz R, Seeger W, Grimminger F, Weissmann N (2008) Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms. Eur Respir J 32:1639\u20131651","journal-title":"Eur Respir J"},{"key":"96_CR63","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","volume":"114","author":"DJ Stewart","year":"1991","unstructured":"Stewart DJ, Levy RD, Cernacek P, Langleben D (1991) Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 114:464\u2013469","journal-title":"Ann Intern Med"},{"key":"96_CR64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.20517\/2574-1209.2018.44","volume":"2","author":"D Strassheim","year":"2018","unstructured":"Strassheim D, Karoor V, Stenmark K, Verin A, Gerasimovskaya E (2018) A current view of G protein-coupled receptor-mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention. Vessel 2:29","journal-title":"Vessel"},{"key":"96_CR65","doi-asserted-by":"publisher","first-page":"L1131","DOI":"10.1152\/ajplung.00067.2020","volume":"318","author":"RM Tudor","year":"2020","unstructured":"Tudor RM, Stenmark KR (2020) Perspective: pathobiological paradigms in pulmonary hypertension, time for reappraisal. Am J Physiol Lung Cell Mol Physiol 318:L1131\u2013L1137","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"96_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.bjp.0706711","volume":"148","author":"T Uemura","year":"2006","unstructured":"Uemura T, Kawasaki T, Taniguchi M, Moritani Y, Hayashi K, Saito T, Takasaki J, Uchida W, Miyata K (2006) Biological properties of a specific Galpha q\/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress. Br J Pharm 148:61\u201369","journal-title":"Br J Pharm"},{"key":"96_CR67","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.healun.2018.11.006","volume":"38","author":"J-L Vachi\u00e9ry","year":"2019","unstructured":"Vachi\u00e9ry J-L, Gali\u00e8 N, Barber\u00e1 JA, Frost AE, Ghofrani H-A, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Blair C et al (2019) Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension\u2012related hospitalization in the AMBITION trial. J Heart Lung Transpl 38:194\u2013202","journal-title":"J Heart Lung Transpl"},{"key":"96_CR68","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.202109-2079PP","volume":"205","author":"CD Vizza","year":"2022","unstructured":"Vizza CD, Lang IM, Badagliacca R, Benza RL, Rosenkranz S, White RJ, Adir Y, Andreassen AK, Balasubramanian V, Bartolome S et al (2022) Aggressive afterload lowering to improve the right ventricle: a new target for medical therapy in pulmonary arterial hypertension? Am J Respir Crit Care Med 205:751\u2013760","journal-title":"Am J Respir Crit Care Med"},{"key":"96_CR69","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jconrel.2016.09.024","volume":"241","author":"S Vosen","year":"2016","unstructured":"Vosen S, Rieck S, Heidsieck A, Mykhaylyk O, Zimmermann K, Plank C, Gleich B, Pfeifer A, Fleischmann BK, Wenzel D (2016) Improvement of vascular function by magnetic nanoparticle-assisted circumferential gene transfer into the native endothelium. J Control Release 241:164\u2013173","journal-title":"J Control Release"},{"key":"96_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105880","volume":"173","author":"JH Voss","year":"2021","unstructured":"Voss JH, Nagel J, Rafehi M, Guix\u00e0-Gonz\u00e1lez R, Malfacini D, Patt J, Kehraus S, Inoue A, K\u00f6nig GM, Kostenis E et al (2021) Unraveling binding mechanism and kinetics of macrocyclic G\u03b1q protein inhibitors. Pharm Res 173:105880","journal-title":"Pharm Res"},{"key":"96_CR71","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1096\/fj.13-246348","volume":"28","author":"J Welschoff","year":"2014","unstructured":"Welschoff J, Matthey M, Wenzel D (2014) RGD peptides induce relaxation of pulmonary arteries and airways via \u03b23-integrins. FASEB J 28:2281\u20132292","journal-title":"FASEB J"},{"key":"96_CR72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/HYPERTENSIONAHA.109.130468","volume":"54","author":"D Wenzel","year":"2009","unstructured":"Wenzel D, Knies R, Matthey M, Klein AM, Welschoff J, Stolle V, Sasse P, R\u00f6ll W, Breuer J, Fleischmann BK (2009) beta(2)-adrenoceptor antagonist ICI 118,551 decreases pulmonary vascular tone in mice via a G(i\/o) protein\/nitric oxide-coupled pathway. Hypertension 54:157\u2013163","journal-title":"Hypertension"},{"key":"96_CR73","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/HYPERTENSIONAHA.111.188367","volume":"59","author":"D Wenzel","year":"2012","unstructured":"Wenzel D, Koch M, Matthey M, Heinemann JC, Fleischmann BK (2012a) Identification of a novel vasoconstrictor peptide specific for the systemic circulation. Hypertension 59:1256\u20131262","journal-title":"Hypertension"},{"key":"96_CR74","doi-asserted-by":"publisher","first-page":"18710","DOI":"10.1073\/pnas.1308130110","volume":"110","author":"D Wenzel","year":"2013","unstructured":"Wenzel D, Matthey M, Bindila L, Lerner R, Lutz B, Zimmer A, Fleischmann BK (2013) Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci USA 110:18710\u201318715","journal-title":"Proc Natl Acad Sci USA"},{"key":"96_CR75","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/s11095-011-0657-5","volume":"29","author":"D Wenzel","year":"2012","unstructured":"Wenzel D, Rieck S, Vosen S, Mykhaylyk O, Trueck C, Eberbeck D, Trahms L, Zimmermann K, Pfeifer A, Fleischmann BK (2012b) Identification of magnetic nanoparticles for combined positioning and lentiviral transduction of endothelial cells. Pharm Res 29:1242\u20131254","journal-title":"Pharm Res"},{"key":"96_CR76","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2125.1996.37117.x","volume":"42","author":"MR Wilkins","year":"1996","unstructured":"Wilkins MR, Zhao L, al-Tubuly R (1996) The regulation of pulmonary vascular tone. Br J Clin Pharm 42:127\u2013131","journal-title":"Br J Clin Pharm"},{"key":"96_CR77","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1161\/01.CIR.102.4.411","volume":"102","author":"DJ Williamson","year":"2000","unstructured":"Williamson DJ, Wallman LL, Jones R, Keogh AM, Scroope F, Penny R, Weber C, Macdonald PS (2000) Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension. Circulation 102:411\u2013418","journal-title":"Circulation"},{"key":"96_CR78","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ame2.12220","volume":"5","author":"X-H Wu","year":"2022","unstructured":"Wu X-H, Ma J-L, Ding D, Ma Y-J, Wei Y-P, Jing Z-C (2022) Experimental animal models of pulmonary hypertension: Development and challenges. Anim Model Exp Med 5:207\u2013216","journal-title":"Anim Model Exp Med"},{"key":"96_CR79","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/jim-2020-001291","volume":"68","author":"S Yaghi","year":"2020","unstructured":"Yaghi S, Novikov A, Trandafirescu T (2020) Clinical update on pulmonary hypertension. J Investig Med 68:821\u2013827","journal-title":"J Investig Med"},{"key":"96_CR80","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.bbrc.2019.06.160","volume":"516","author":"X Yan","year":"2019","unstructured":"Yan X, Wang J, Zhu Y, Feng W, Zhai C, Liu L, Shi W, Wang Q, Zhang Q, Chai L et al (2019) S1P induces pulmonary artery smooth muscle cell proliferation by activating calcineurin\/NFAT\/OPN signaling pathway. Biochem Biophys Res Commun 516:921\u2013927","journal-title":"Biochem Biophys Res Commun"},{"key":"96_CR81","doi-asserted-by":"publisher","first-page":"eaaz5660","DOI":"10.1126\/scitranslmed.aaz5660","volume":"12","author":"L-M Yung","year":"2020","unstructured":"Yung L-M, Yang P, Joshi S, Augur ZM, Kim SSJ, Bocobo GA, Dinter T, Troncone L, Chen P-S, McNeil ME et al (2020) ACTRIIA-Fc rebalances activin\/GDF versus BMP signaling in pulmonary hypertension. Sci Transl Med 12:eaaz5660","journal-title":"Sci Transl Med"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00096-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:03:47Z","timestamp":1785848627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00096-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":81,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,12]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00096-0","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"23 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"7"}}